Body composition measures as a determinant of Alpelisib related toxicity

ConclusionBody composition measures, specifically SMD and VAT may provide an opportunity to identify patients at higher risk for severe alpelisib related hyperglycemia, and cutaneous toxicity. These findings suggest the potential use of body composition assessment to caution toxicity risk, allowing for personalized therapeutic observation and intervention.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research